Abstract
This paper examines how the laws of six countries in South-East Asia (Singapore, Malaysia, Philippines, Indonesia, Vietnam and Thailand) fit within the WTO TRIPS and regional trade agreement regime for pharmaceutical patents. It examines the laws under the headings of patentability, patent administration, generics to market (preparation for market and compulsory licensing) and trade in pharmaceuticals (parallel importation and compulsory licensing). Its interest lies with drug development and access to medicines. In addition to the reading of the legal texts, note is made of any empirical studies of the impact of the laws.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
